1. Home
  2. BFC vs ZYME Comparison

BFC vs ZYME Comparison

Compare BFC & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank First Corporation

BFC

Bank First Corporation

HOLD

Current Price

$155.29

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$21.81

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFC
ZYME
Founded
1894
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
BFC
ZYME
Price
$155.29
$21.81
Analyst Decision
Buy
Strong Buy
Analyst Count
2
11
Target Price
$157.00
$38.90
AVG Volume (30 Days)
82.1K
412.3K
Earning Date
04-16-2026
05-07-2026
Dividend Yield
1.52%
N/A
EPS Growth
11.23
33.33
EPS
1.78
N/A
Revenue
N/A
$105,965,000.00
Revenue This Year
$58.67
$183.10
Revenue Next Year
$2.01
N/A
P/E Ratio
$85.81
N/A
Revenue Growth
N/A
38.87
52 Week Low
$115.29
$11.86
52 Week High
$154.42
$29.75

Technical Indicators

Market Signals
Indicator
BFC
ZYME
Relative Strength Index (RSI) 64.11 35.87
Support Level $134.81 $17.27
Resistance Level N/A $23.66
Average True Range (ATR) 4.97 0.83
MACD 0.53 -0.24
Stochastic Oscillator 91.09 13.04

Price Performance

Historical Comparison
BFC
ZYME

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services, a full range of consumer and commercial financial institution services to individuals and businesses, including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: